Delivery Order SPE2DB20D2104-SPE2DB26FMAQZ
Award Date 10/22/25
Potential Completion Date 10/23/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Clindamycin Phosphate 1% Foam in 50-gram units, valued at $1,315.27. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its principal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Clindamycin Phosphate 1% Foam in 50-gram units. This is a firm fixed price contract with a ceiling value of $1,806.94 and an ultimate completion date of September 19, 2025. The award was made without a set-aside designation through competitive procurement, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,323.00 to AmerisourceBergen Drug Corp for Clindamycin Phosphate 1% Foam 50GM on August 20, 2025, with completion expected by August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The pharmaceutical product will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,252.08 to AmerisourceBergen Drug Corp for Clindamycin Phosphate 1% Foam 50GM, a topical antibiotic pharmaceutical product. The contract, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance of work also...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Clindamycin Phosphate 1% Foam in 100-gram units, with a ceiling value of $1,208.38. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Clindamycin Phosphate 1% Foam in 50-gram units, with a ceiling value of $11,750.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The ultimate completion date is September 8, 2025, and the product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $25,629.43 to AmerisourceBergen Drug Corp for the supply of Clindamycin Phosphate 1% Foam 100GM on September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the pharmaceutical distributor. The products will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Clindamycin Phosphate 1% Foam (100 grams) with a ceiling value of $1,553.04. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $2,491.58 for Clindamycin Phosphate 1% Foam 50GM, a topical antibiotic medication. The contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a firm fixed-price procurement with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,347.82 to AmerisourceBergen Drug Corp for the supply of Clindamycin Phosphate 1% Foam in 100GM units. This award, issued on August 21, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...